Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
3Y CAGR-9.0%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-9.0%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202513.56+0.8%
202413.45-9.8%
202314.91-17.0%
202217.97-74.7%
202170.91+227.4%
2020-55.67-259.0%
2019-15.51+66.0%
2018-45.68-